I’m often asked: “why did you choose to be a GI oncologist?” 🚨THIS is why. Because 5 of the 10 deadliest cancers are GI, 🚨& zero GI cancers enjoy top survival. What could be a clearer call to action? Let’s get after it, team! 💪🏼 #GICSM Thanks Ajay Aggarwal for highlighting this

Check out Dr. Lorenza Rimassa Lorenza Rimassa
discussing #ESMO23 'Personalized Medicine and Targeted Agents for Biliary Tract Cancer'

#livercancer #HCC #biliarytractcancer #GICSM
Full video on #VuMedi
👇
bit.ly/ESMO23BTC

LISTEN NOW: In the latest episode of Emerging Experts, Michael LaPelusa, MD shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers. #GICSM | MD Anderson Cancer Center

targetedonc.com/view/lapelusa-…

Check out Dr. Ibrahim Sahin Ibrahim Halil SAHIN, MD UPMC Hillman Cancer Center discussing Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Full 📽️ on #VuMedi
👇
bit.ly/YOCC

#ColorectalCancer AwarenessMonth University of Pittsburgh
#OncEd #gicsm #OncTwitter #oncology #CRCSM #ColorectalCancer

THANK YOU to all who supported the GI Cancer Institute and AGITG #gutsychallenge today! 👣 🥾 All funds going towards vital research and #clinicaltrials for gastrointestinal cancers 💊 🔬 bit.ly/Gut5y2 #AGITG #GICSM

#CedarsSinaiCancer at #GI23 . Dr. Ju Dong Yang Ju Dong Yang is co-author on a prospective clinical trial evaluating the performance of a multi-analyte blood test for early detection of #hepatocellularcarcinoma among at-risk patients with liver #cirrhosis . Cedars-Sinai Academic Medicine #gicsm

At #ESMO23 , Yelena Y. Janjigian MD presented final progression-free survival + interim overall survival results of pembrolizumab plus trastuzumab and chemotherapy as first-line therapy for HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma. #gicsm Memorial Sloan Kettering Cancer Center

Atualização Diretrizes ASCO 2024: Tratamento Sistêmico para Carcinoma Hepatocelular Avançado

Confira o texto completo em: ascopubs.org/doi/10.1200/JC…

Veja mais sobre #HCC em: mocbrasil.com

#GIcsm Ricardo Carvalho cayamada ASCO Journal of Clinical Oncology

We’re looking fwd to learning from an all-star lineup of #KOLs in #gicsm #MedTwitter @HJLenz59 Eileen M O’Reilly Ghassan Abou-Alfa Mark Lewis Pamela Kunz, MD, FASCO Franco Roviello Tanios Bekaii-Saab, MD Vinay Prasad MD MPH + personally curated art tour Dr. Andrew Hendifar 😉 Register now: cedars.cloud-cme.com/gicancercme #CME

Nothing like being at the Arie Crown Theater - kicking off the GI Cancers Session. #ASCO23

Immuno-oncology beyond checkpoint inhibitors.

#Immunotherapy ASCO #GICSM #PrecisionMedicine #PrecisionOncology

Thrilled to celebrate Deborah Schrag today at #ASCO23 . She will be receiving the ASCO-American Cancer Society Society Cancer Prevention Award for her significant contributions to cancer prevention & control. Tune into her lecture at noon CT: #gicsm Memorial Sloan Kettering Cancer Center ow.ly/Wps650OE8j8

#CedarsSinaiCancer at #GI23 . The poster “Development of artificial intelligence–derived histological #biomarkers for first-line treatment selection in metastatic #pancreatic ductal #adenocarcinoma ” will be presented today at 12pm PT. #AI Dr. Andrew Hendifar Cedars-Sinai Academic Medicine #gicsm

Management of CRC continues to evolve w/ the intro of new targeted therapies & strategies. An Ed. Session at #ASCO24 will review recent advances & ongoing trials aimed at further improving outcomes: brnw.ch/21wJVF0 #ASCODailyNews #GICSM #colorectalcancer #crcsm Dustin Deming

A recording of Dr. Kimmie Ng, MD, MPH's #GI24 keynote lecture is now available, 'The Growing Problem of Early-Onset Gastrointestinal Cancers.'

Watch here ➡️ brnw.ch/21wGg4Z #gicsm #OncTwitter

We’ve issued a guideline update on systemic therapy for advanced #HepatocellularCarcinoma : brnw.ch/21wI1IN #gicsm

#CedarsSinaiCancer at #GI23 . Dr. Jun Gong Jun Gong is co-author on the poster “Molecular characterization and clinical outcomes of #pancreatic neuroendocrine #tumors harboring PAK4-NAMPT alterations.” presented at 12pm PT today Cedars-Sinai Academic Medicine #gicsm

#CedarsSinaiCancer at #GI23 . Dr. Vi Chiu Vi K. Chiu MD PhD is co-author on the poster “ #Pertuzumab plus #trastuzumab in patients with biliary tract #cancer with ERBB2/3 amplification, overexpression, or mutation” presented at 12pm PT today. Cedars-Sinai Academic Medicine The Angeles Clinic #gicsm

New from #GI24 and #ASCOEdBook : Updates on systemic therapy for #HepatocellularCarcinoma : brnw.ch/21wGeWr #gicsm #LiverCancer

David H. Ilson of Memorial Sloan Kettering Cancer Center will talk about the timing of immunotherapy in localized gastroesophageal junction and #gastriccancer today from 3:09 p.m. to 3:21 p.m. CT at #ASCO23 . #gicsm ow.ly/jUEf50OEbNq

The #GI23 annual meeting will be starting this week on 1/19 – 1/21. Follow @CSCancerCare for presentations & posters by Cedars-Sinai & #CedarsSinaiCancer clinicians and researchers. See the attached schedules for highlights! Cedars-SinaiMed #gicsm
conferences.asco.org/gi/attend